.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Plenary session

PS 5
PS 5 | Trial designs that lead to medication availability in Europe

Appointment

Date: 09/12/2023

Time: 08:30 – 09:30

Location / Stream:

Plenary hall

Chair

Programme

Plenary lecture
Is a comparison of new substances to placebo sufficient?
Hans-Christoph Diener (Essen, DE)
Plenary lecture
How to bring new migraine drugs to patients in Europe
Michel D. Ferrari (Leiden, NL)
Plenary lecture
New ideas for trials in cluster headache
Peter J. Goadsby (London, GB)

PS 5PS 5 | Trial designs that lead to medication availability in Europe

Appointment

Chair

Programme

PS 5
PS 5 | Trial designs that lead to medication availability in Europe